Key result
Triglyceride-glucose index offers only modest improvement in predicting mortality over established risk factors.
Why the study?
While the Triglyceride-Glucose Index is a recognized risk factor for mortality in populations such as T2DM and cardiovascular disease, its prognostic role in obese individuals remains less clear.
Does the Triglyceride-Glucose Index (TYG) improve mortality prediction beyond established risk factors in obese and general populations?
Cohort (n=16,626)
Yes
Does the Triglyceride-Glucose Index (TYG) improve mortality prediction beyond established risk factors in obese and general populations?
Answers are grounded in this paper and cite their sources.
The Triglyceride-Glucose Index provides only modest incremental prognostic value for predicting mortality beyond established clinical risk factors.
Background/Objectives: Recent studies have highlighted the Triglyceride–Glucose Index (TYG) as a significant risk factor for mortality and co-morbidities in various populations, including those with type 2 diabetes mellitus (T2DM) and cardiovascular diseases. However, its prognostic role in obese individuals remains less clear. Methods: Utilizing data from an obese cohort of 1359 subjects and from the 1999–2004 cycles of the National Health and Nutrition Examination Survey (NHANES) with 15,267 subjects, this study investigates the prognostic value of TYG and blood glucose in relation to age and sex and other factors such as metabolic syndrome, Charlson Comorbidity Index, T2DM and glucose tolerance, in predicting mortality among obese subjects. Over a median follow-up of about 13 years, 11.3% of the obese cohort and 20.6% of the NHANES cohort died. Our findings indicate that while TYG and blood glucose are significantly related to mortality, they offer only modest improvements over models incorporating age, sex, and other risk factors that showed a prognostic power of 76.1% and 86.0% in the respective cohorts. Conclusions: These results suggest that while TYG holds potential as a prognostic biomarker, its utility beyond established risk factors requires further validation in clinical settings.
No takes yet. Share an insight, caveat, or question.
Pontiroli et al. (2025) conducted a cohort in Obesity (n=16,626). Triglyceride-Glucose Index (TYG) vs. Established risk factors was evaluated on Mortality. The Triglyceride-Glucose Index offered only modest improvements in predicting mortality over established risk factors, which had prognostic powers of 76.1% and 86.0%.
Synapse has enriched 10 related papers. Consider them for comparative context: